SWP
BHVN

ShoreHaven Wealth Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

ShoreHaven Wealth Partners’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,794
Closed -$247K – 73
2021
Q4 		$247K Sell
1,794
-15
-0.8% -$1.91K 0.12% 42
2021
Q3 		$251K Sell
1,809
-630
-26% -$78.7K 0.13% 40
2021
Q2 		$236K Hold
2,439
– – 0.13% 48
2021
Q1 		$167K Sell
2,439
-530
-18% -$42.9K 0.09% 61
2020
Q4 		$255K Buy
+2,969
New +$252K 0.14% 43

Other funds holding BHVN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $153M AUM 42.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return